---
category: disclosure
circular_id: ebabbc17e3fdd27e
date: '2025-10-21'
description: Companies provide clarifications to BSE regarding recent price and volume
  movements in their securities, confirming compliance with disclosure requirements
  and stating no pending material information.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={F4B01E8D-3E92-4780-9B15-D8113CC8C829}&noticeno=20251021-3&dt=10/21/2025&icount=3&totcount=4&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine clarifications provided by companies in response to BSE queries
  about price/volume movements. No new material information disclosed, companies confirm
  compliance with existing disclosure norms.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251021-3&attachedId=c2dc1c17-da32-47fc-8189-7ae8ef796b52
processing:
  attempts: 1
  content_hash: 4a403786812cf880
  processed_at: '2025-10-21T12:43:01.741691'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-21T11:08:12+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={F4B01E8D-3E92-4780-9B15-D8113CC8C829}&noticeno=20251021-3&dt=10/21/2025&icount=3&totcount=4&flag=0
severity: low
source: bse
stocks:
- SHANTHI
- APTUS
- PRISMJOHNS
tags:
- price-movement
- volume-movement
- clarification
- disclosure
- regulation-30
- sebi-lodr
title: Clarifications received from the companies on price and volume movements
---

## Summary

BSE received clarifications from three companies - Shanthi Gears Limited, Aptus Pharma Limited, and Prism Johnson Ltd - regarding unusual price and/or volume movements in their securities. All companies confirmed that they have complied with Regulation 30 of SEBI LODR Regulations 2015 for disclosure of price-sensitive information and stated that no material information is pending disclosure. The companies clarified that price movements are market-driven and not influenced by undisclosed material events.

## Key Points

- **Shanthi Gears Limited** (BSE Scrip: 522034) responded to BSE letter dated October 21, 2025 regarding increase in trading volume
- **Aptus Pharma Limited** (BSE Scrip: 544529) responded to BSE letter dated October 17, 2025 regarding price movement
- **Prism Johnson Ltd** response date October 21, 2025 (letter appears incomplete in source document)
- All companies confirmed compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Companies stated no price-sensitive information is pending disclosure to stock exchanges
- Aptus Pharma specifically noted that price movement is purely market-driven with no management involvement

## Regulatory Changes

No regulatory changes announced. This circular relates to routine compliance with existing Regulation 30 of SEBI LODR Regulations 2015.

## Compliance Requirements

- Companies are required to respond promptly to stock exchange queries regarding unusual price or volume movements
- Companies must confirm whether any undisclosed material information exists that could impact security prices
- Ongoing obligation to disclose price-sensitive information in timely manner under Regulation 30 of SEBI LODR

## Important Dates

- **October 17, 2025**: BSE query sent to Aptus Pharma Limited
- **October 18, 2025**: Aptus Pharma Limited response submitted
- **October 21, 2025**: BSE query sent to Shanthi Gears Limited; response submitted same day
- **October 21, 2025**: Prism Johnson Ltd response date

## Impact Assessment

**Market Impact**: Low - These are routine clarifications with no new material information disclosed. Companies confirmed normal market operations.

**Investor Impact**: Low - No undisclosed material events affecting these companies. Provides reassurance that companies are compliant with disclosure norms.

**Compliance Impact**: Low - Standard regulatory procedure where exchanges seek clarifications on unusual price/volume movements to ensure market integrity and timely disclosure.